Trial · NCT00716079
Adverse events24
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 24
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Direct effects of primary ICH event | General disorders | Intensive Blood-Pressure Lowering | 143 | 1,399 | |
| serious | Direct effects of primary ICH event | General disorders | Guideline-Recommended Blood-Pressure Lowering | 154 | 1,430 | |
| serious | ICH | Vascular disorders | Intensive Blood-Pressure Lowering | 5 | 1,399 | |
| serious | ICH | Vascular disorders | Guideline-Recommended Blood-Pressure Lowering | 7 | 1,430 | |
| serious | Ischaemic/undifferentiated stroke | Vascular disorders | Intensive Blood-Pressure Lowering | 9 | 1,399 | |
| serious | Ischaemic/undifferentiated stroke | Vascular disorders | Guideline-Recommended Blood-Pressure Lowering | 8 | 1,430 | |
| serious | Acute MI/coronary event/other | Cardiac disorders | Intensive Blood-Pressure Lowering | 5 | 1,399 | |
| serious | Acute MI/coronary event/other | Cardiac disorders | Guideline-Recommended Blood-Pressure Lowering | 6 | 1,430 | |
| serious | Other vascular disease | Vascular disorders | Intensive Blood-Pressure Lowering | 15 | 1,399 | |
| serious | Other vascular disease | Vascular disorders | Guideline-Recommended Blood-Pressure Lowering | 16 | 1,430 | |
| serious | Other cardiac disease | Cardiac disorders | Intensive Blood-Pressure Lowering | 24 | 1,399 | |
| serious | Other cardiac disease | Cardiac disorders | Guideline-Recommended Blood-Pressure Lowering | 27 | 1,430 | |
| serious | Renal failure | Renal and urinary disorders | Intensive Blood-Pressure Lowering | 6 | 1,399 | |
| serious | Renal failure | Renal and urinary disorders | Guideline-Recommended Blood-Pressure Lowering | 11 | 1,430 | |
| serious | Severe hypotension | Vascular disorders | Intensive Blood-Pressure Lowering | 8 | 1,399 | |
| serious | Severe hypotension | Vascular disorders | Guideline-Recommended Blood-Pressure Lowering | 12 | 1,430 | |
| serious | Respiratory infections | Infections and infestations | Intensive Blood-Pressure Lowering | 66 | 1,399 | |
| serious | Respiratory infections | Infections and infestations | Guideline-Recommended Blood-Pressure Lowering | 77 | 1,430 | |
| serious | Sepsis (includes other infections) | Infections and infestations | Intensive Blood-Pressure Lowering | 26 | 1,399 | |
| serious | Sepsis (includes other infections) | Infections and infestations | Guideline-Recommended Blood-Pressure Lowering | 24 | 1,430 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00716079/events